Results 201 to 210 of about 12,119 (223)

Neuromyelitis optica spectrum disorders in Iran

Multiple Sclerosis and Related Disorders, 2017
Neuromyelitys optica spectrum disorder (NMOSD) is a rare demyelinating disease; as a result, the epidemiological data on this disorder is scarce. In this regard, the aim of this study was to estimate the prevalence, serology, and clinical features of NMOSD in Caucasian population in Tehran, Iran.A cross sectional study was performed in Tehran from 2015
Sharareh, Eskandarieh, Saharnaz, Nedjat, Amir Reza, Azimi, Abdorreza Naser, Moghadasi, Mohammad Ali, Sahraian   +4 more
openaire   +2 more sources

Neuromyelitis Optica Spectrum Disorders

Journal of Immunological Techniques & Infectious Diseases, 2018
Corinna Trebst, Ilya Ayzenberg, Ingo Kleiter   +2 more
openaire   +2 more sources

Biotinidase Deficiency as a Mimic of Neuromyelitis Optica Spectrum Disorder in Childhood

JAMA Neurology, 2021
Jonathan D Santoro
exaly  

Optical coherence tomography angiography indicates subclinical retinal disease in neuromyelitis optica spectrum disorders

Multiple Sclerosis Journal, 2022
Lilian Aly, Nikolaus Feucht, Achim Berthele   +2 more
exaly  

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Lancet, The, 2019
Petra Nytrova, Jeffrey L Bennett, Ho Jin Kim   +2 more
exaly  

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Lancet, The, 2004
Dean M Wingerchuk, Sean J Pittock, Ichiro Nakashima   +2 more
exaly  

Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders

JAMA Neurology, 2016
Valentina Damato, Amelia Evoli, Raffaele Iorio   +2 more
exaly  

Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG–Associated Disorders

JAMA Neurology, 2020
Amy Kunchok, John J Chen, Dean M Wingerchuk   +2 more
exaly  

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

New England Journal of Medicine, 2019
Takashi Yamamura, Ingo Kleiter, Kazuo Fujihara   +2 more
exaly  

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies

JAMA Neurology, 2014
Patrick Waters, Wilhelm Kuker, Angela Vincent   +2 more
exaly